On Jan 08, McLean Emmett E, Executive Vice President & COO sold 100,000 shares of Medical Properties Trust Inc. (NYSE: MPW), with the average selling price of the stock being $20.84 per share. The total amount realized from this sold $2,084,000. A document was filed with the Securities and Exchange Commission to notify the public about the sold of the shares.
In addition to that, Director – Stewart Michael G sold an extra 4,800 shares of this stock in a transaction that took place a day before, on Dec 04, with a share sold at an average of $21.08 and a total of $101,184 was realized from this transaction. After the transaction, the Director – Stewart Michael G was left with 219,815 shares of the company’s stock, which is currently worth around $4633700.2.
The recent price movement of MPW means that it is now down by -0.26% from its 52-week high and 35.23% up against its 52-week low prices. Over the past one week, the price volatility of MPW stands at 1.60% while the volatility over the past one month is 1.57%. The beta score for this stock is 0.62. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company published its latest quarterly earnings, with the report showing that the company recorded 0.21 earnings per share (EPS) during that period. This report was below the expectations of analysts of 0.22 by -0.01. The revenue by the firm was 263.22M for the quarter.
The shares of Medical Properties Trust Inc. (MPW) gained by 0.57%, leading to a gain of $0.13 per share, and saw MPW end the trading session at $22.76 on Wednesday 02/05/20. MPW started the trading session at $22.70, before reaching a daily high of $22.775. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $22.49.
The trading volume on Wednesday stood at 3415392, which was below the stock’s 3-month average volume of 5.74 million shares, out of a total 512.84M shares. As the price of the stock climbed, the market valuation of the company gained to 11.95 billion.
The shares of Hormel Foods Corporation (NYSE: HRL) went down by -0.34% by the end of the recent trading session. This movement saw its price plunge to close at $47.39, which was lower than the previous closing price of $47.55. Over the past one week, the price of HRL has jumped by 0.15%, while it has recorded a gain of 7.05% over the past one month. Its three-month performance saw HRL gain 13.70% while its six-month performance saw it surge by 16.95%. The situation is different though over the past one year, as the stock price went up by 12.41%, while its year-to-date (YTD) price performance jumped by 5.05%. The stock price has gone up by +14.66% compared to its 90-day low, while it is down -1.29% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Buy. In the short-term, the stock has a 20-day average volume of 2,367,165 shares, with the short-term indicators averagely rating the stock as a 100% Buy. A look at its medium-term indicators reveals that it has a 50-Day average volume of 2,507,542 shares and the indicators have an average rating of 100% Buy. The last indicators, the long-term see HRL stock with a 100-Day average volume of 2,243,399 shares, giving it an average rating of 100% Buy. A look at the general picture of all short, medium and long-term indicators leaves HRL with an average rating of 100% Buy.
Several brokerage firms sent out their reports HRL stock not long ago. In its report sent out on October 25, 2019, BofA/Merrill lowered its ratings on HRL to a Underperform. In an earlier report on June 12, 2019, Edward Jones Downgrade the stock from a Buy to a Hold. JP Morgan meanwhile in its report on April 23, 2019 Downgrade its rating of the stock from a “Underweight” to “Underweight”.
In related news to the company’s stock, around 46.20% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 618 institutions currently hold the HRL stock. In the last quarter, a 235,412,726 HRL shares were in the possession of institutions. On the other hand, the company recorded 65 new institutions who bought it their stock, while 39 institutions sold their entire HRL reserve. Of the current institutions investing in the stock, 288 increased their investment while 232 decreased their investment in the stock.